198 related articles for article (PubMed ID: 38069151)
1. Safety and Feasibility of Intradiscal Administration of Matrilin-3-Primed Adipose-Derived Mesenchymal Stromal Cell Spheroids for Chronic Discogenic Low Back Pain: Phase 1 Clinical Trial.
Lee DH; Park KS; Shin HE; Kim SB; Choi H; An SB; Choi H; Kim JP; Han I
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069151
[TBL] [Abstract][Full Text] [Related]
2. Safety and tolerability of intradiscal implantation of combined autologous adipose-derived mesenchymal stem cells and hyaluronic acid in patients with chronic discogenic low back pain: 1-year follow-up of a phase I study.
Kumar H; Ha DH; Lee EJ; Park JH; Shim JH; Ahn TK; Kim KT; Ropper AE; Sohn S; Kim CH; Thakor DK; Lee SH; Han IB
Stem Cell Res Ther; 2017 Nov; 8(1):262. PubMed ID: 29141662
[TBL] [Abstract][Full Text] [Related]
3. Treatment of discogenic back pain with autologous bone marrow concentrate injection with minimum two year follow-up.
Pettine K; Suzuki R; Sand T; Murphy M
Int Orthop; 2016 Jan; 40(1):135-40. PubMed ID: 26156727
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of matrilin-3-primed adipose-derived mesenchymal stem cell spheroids in a rabbit model of disc degeneration.
Muttigi MS; Kim BJ; Kumar H; Park S; Choi UY; Han I; Park H; Lee SH
Stem Cell Res Ther; 2020 Aug; 11(1):363. PubMed ID: 32831130
[TBL] [Abstract][Full Text] [Related]
5. Allogeneic mesenchymal precursor cells treatment for chronic low back pain associated with degenerative disc disease: a prospective randomized, placebo-controlled 36-month study of safety and efficacy.
Amirdelfan K; Bae H; McJunkin T; DePalma M; Kim K; Beckworth WJ; Ghiselli G; Bainbridge JS; Dryer R; Deer TR; Brown RD
Spine J; 2021 Feb; 21(2):212-230. PubMed ID: 33045417
[TBL] [Abstract][Full Text] [Related]
6. Clinical Evaluation and Magnetic Resonance Imaging Assessment of Intradiscal Methylene Blue Injection for the Treatment of Discogenic Low Back Pain.
Zhang X; Hao J; Hu Z; Yang H
Pain Physician; 2016; 19(8):E1189-E1195. PubMed ID: 27906950
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and cost-effectiveness of intradiscal methylene blue injection for chronic discogenic low back pain: study protocol for a randomized controlled trial.
Geurts JW; Kallewaard JW; Kessels A; Willems PC; van Santbrink H; Dirksen C; van Kleef M
Trials; 2015 Nov; 16():532. PubMed ID: 26590962
[TBL] [Abstract][Full Text] [Related]
8. Intradiscal injection therapy for degenerative chronic discogenic low back pain with end plate Modic changes.
Cao P; Jiang L; Zhuang C; Yang Y; Zhang Z; Chen W; Zheng T
Spine J; 2011 Feb; 11(2):100-6. PubMed ID: 20850390
[TBL] [Abstract][Full Text] [Related]
9. Pain Relief After Allogenic Stem Cell Disc Therapy.
Lewandrowski KU; Dowling A; Vera JC; Leon JFR; Telfeian AE; Lorio MP
Pain Physician; 2023 Mar; 26(2):197-206. PubMed ID: 36988365
[TBL] [Abstract][Full Text] [Related]
10. Autologous bone marrow concentrate intradiscal injection for the treatment of degenerative disc disease with three-year follow-up.
Pettine KA; Suzuki RK; Sand TT; Murphy MB
Int Orthop; 2017 Oct; 41(10):2097-2103. PubMed ID: 28748380
[TBL] [Abstract][Full Text] [Related]
11. Effect of age on outcomes after allogeneic disc tissue supplementation in patients with chronic discogenic low back pain in the VAST trial.
Hunter CW; Guyer R; Froimson M; DePalma MJ
Pain Manag; 2022 Apr; 12(3):301-311. PubMed ID: 34875850
[TBL] [Abstract][Full Text] [Related]
12. Intradiscal platelet-rich plasma (PRP) injections for discogenic low back pain: an update.
Monfett M; Harrison J; Boachie-Adjei K; Lutz G
Int Orthop; 2016 Jun; 40(6):1321-8. PubMed ID: 27073034
[TBL] [Abstract][Full Text] [Related]
13. Intradiscal pulsed radiofrequency for chronic lumbar discogenic low back pain: a one year prospective outcome study using discoblock for diagnosis.
Fukui S; Nitta K; Iwashita N; Tomie H; Nosaka S; Rohof O
Pain Physician; 2013; 16(4):E435-42. PubMed ID: 23877468
[TBL] [Abstract][Full Text] [Related]
14. Preclinical Animal Study and Pilot Clinical Trial of Using Enriched Peripheral Blood-Derived Mononuclear Cells for Intervertebral Disc Degeneration.
Chung YH; Hu MH; Kao SC; Kao YH; Wang FH; Hsieh CY; Shen CI; Chuang CH; Chen DW; Kuo CC; Su HL; Lin CL
Cell Transplant; 2024; 33():9636897231219733. PubMed ID: 38173231
[TBL] [Abstract][Full Text] [Related]
15. Intradiscal Pulsed Radiofrequency Application Duration Effect on Lumbar Discogenic Low Back Pain.
Park CH; Lee SH; Lee PB
Pain Physician; 2020 Sep; 23(5):E535-E540. PubMed ID: 32967404
[TBL] [Abstract][Full Text] [Related]
16. Single intradiscal injection of the interleukin-6 receptor antibody tocilizumab provides short-term relief of discogenic low back pain; prospective comparative cohort study.
Sainoh T; Orita S; Miyagi M; Inoue G; Yamauchi K; Suzuki M; Sakuma Y; Kubota G; Oikawa Y; Inage K; Sato J; Nakata Y; Aoki Y; Takahashi K; Ohtori S
J Orthop Sci; 2016 Jan; 21(1):2-6. PubMed ID: 26755382
[TBL] [Abstract][Full Text] [Related]
17. Disc height discrepancy between supine and standing positions as a screening metric for discogenic back pain in patients with disc degeneration.
Son S; Lee SG; Kim WK; Ahn Y; Jung JM
Spine J; 2021 Jan; 21(1):71-79. PubMed ID: 32687982
[TBL] [Abstract][Full Text] [Related]
18. [Intradiscal interventional therapy for degenerative chronic discogenic low back pain with end-plate Modic changes].
Zhuang CY; Cao P; Zheng T; Yang YQ; Zhang ZW; Chen W
Zhonghua Yi Xue Za Zhi; 2009 Sep; 89(35):2490-4. PubMed ID: 20137437
[TBL] [Abstract][Full Text] [Related]
19. Efficacy, Safety, and Predictors of Intradiscal Methylene Blue Injection for Discogenic Low Back Pain: Results of a Multicenter Prospective Clinical Series.
Kallewaard JW; Geurts JW; Kessels A; Willems P; van Santbrink H; van Kleef M
Pain Pract; 2016 Apr; 16(4):405-12. PubMed ID: 25753429
[TBL] [Abstract][Full Text] [Related]
20. Autologous cultured adipose derived mesenchymal stem cells combined with hyaluronic acid hydrogel in the treatment of discogenic low back pain: a study protocol for a phase II randomised controlled trial.
Zhang J; Sun T; Zhang W; Yang M; Li Z
BMJ Open; 2022 Oct; 12(10):e063925. PubMed ID: 36283750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
